81_FR_82010 81 FR 81787 - Submission for OMB Review; 30-Day Comment Request: A National Survey of Nurse Coaches (NIH Clinical Center)

81 FR 81787 - Submission for OMB Review; 30-Day Comment Request: A National Survey of Nurse Coaches (NIH Clinical Center)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 223 (November 18, 2016)

Page Range81787-81788
FR Document2016-27839

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on August 22, 2016, pages 56668-9 (81 FR 56668) and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment.

Federal Register, Volume 81 Issue 223 (Friday, November 18, 2016) 
[Federal Register Volume 81, Number 223 (Friday, November 18, 2016)]
[Notices]
[Pages 81787-81788]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-27839]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request: A National 
Survey of Nurse Coaches (NIH Clinical Center)

AGENCY: National Institutes of Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the 
National Institutes of Health (NIH) has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below. This proposed information 
collection was previously published in the Federal Register on August 
22, 2016, pages 56668-9 (81 FR 56668) and allowed 60-days for public 
comment. No public comments were received. The purpose of this notice 
is to allow an additional 30 days for public comment.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received by December 19, 2016.

ADDRESSES: Written comments and/or suggestions regarding the item(s) 
contained in this notice, especially regarding the estimated public 
burden and associated response time, should be

[[Page 81788]]

directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: Desk Officer for NIH.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact: Dr. Alyson Ross, Nurse Researcher, Department of 
Nursing Research and Translational Science, NIH Clinical Center, 
Building 10, Room 2B07, MSC-1151, Bethesda, Maryland, 20892 or call 
non-toll-free number (301) 451-8338 or Email your request, including 
your address to: [email protected]. Formal requests for additional 
plans and instruments must be requested in writing.

SUPPLEMENTARY INFORMATION: The NIH Clinical Center, National Institutes 
of Health, may not conduct or sponsor, and the respondent is not 
required to respond to, an information collection that has been 
extended, revised, or implemented on or after October 1, 1995, unless 
it displays a currently valid OMB control number.
    In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction 
Act of 1995, the National Institutes of Health (NIH) has submitted to 
the Office of Management and Budget (OMB) a request for review and 
approval of the information collection listed below.
    Proposed Collection: A National Survey of Nurse Coaches, 0925-NEW, 
National Institutes of Health Clinical Center (NIHCC), National 
Institutes of Health (NIH).
    Need and Use of Information Collection: The purpose of this survey 
is to describe the role of Certified Nurse Coaches in order to gain 
insight into their clinical practice including: The settings in which 
they work, the types of clients/health conditions they see, the types 
of client records maintained and outcomes followed, as well as the 
personal benefits experienced by nurse coaches as a result of becoming 
a nurse coach. It provides information regarding two areas of interest 
to the Department of Nursing Research and Translational Science: The 
collection of patient-reported outcomes in novel clinical practice 
areas and the physical and psychosocial benefits of an intervention in 
nurses, a professional caregiver population. This study will provide 
preliminary data and guidance in: (1) Developing recommendations for 
collecting outcomes to longitudinally assess the effectiveness nurse 
coaching, and (2) developing an intervention to improve patient care 
and patient satisfaction targeting the nursing staff at the NIH 
Clinical Center.
    OMB approval is requested for 1 year. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 104.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Certified Nurse Coaches.........................             250               1           25/60             104
                                                 ---------------------------------------------------------------
    Total.......................................             250             250  ..............             104
----------------------------------------------------------------------------------------------------------------


    Dated: November 9, 2016.
Laura M. Lee,
Project Clearance Liaison, NIH Clinical Center, National Institutes of 
Health.
[FR Doc. 2016-27839 Filed 11-17-16; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 223 / Friday, November 18, 2016 / Notices 81787 future DMICC meetings should register lead molecules may be useful to treat Inventor(s): Amy Newman and Vivek for the listserv available on the DMICC drug addiction/dependence. Kumar (NIDA). Web site, www.diabetescommittee.gov. Description of Technology: Dopamine Intellectual Property: E–053–2016 Dated: November 9, 2016. is a major neurotransmitter in the United States Provisional Patent B. Tibor Roberts, central nervous system and among other Application No. 62/307,600, filed March functions is directly related to the 14, 2016, titled ‘‘Dopamine D3 Receptor Executive Secretary, Office of Scientific Program and Policy Analysis, National rewarding effects of drugs of abuse. Selective Antagonists/Partial Agonists; Institute of Diabetes and Digestive and Kidney Dopamine signaling is mediated by D1, Methods of Making and Use Thereof’’. Diseases, National Institutes of Health. D2, D3, D4 and D5 receptors. The Publications: J Med Chem. 2016 Aug [FR Doc. 2016–27825 Filed 11–17–16; 8:45 am] dopamine D3 receptor is a known target 25;59(16):7634–50. doi: 10.1021/ to treat a variety of neuropsychiatric acs.jmedchem.6b00860. Epub 2016 Aug BILLING CODE 4140–01–P disorders, including substance use 10. disorders (e.g. cocaine and opioid), Collaboration Opportunity: DEPARTMENT OF HEALTH AND schizophrenia and depression. Despite Researchers at the NIDA seek licensing HUMAN SERVICES extensive efforts, it has proven difficult and/or co-development research to identify a lead molecule that collaborations for development of National Institutes of Health selectively binds to D3 receptors (versus Dopamine D3 ligands to treat opioid use D2 receptors, for example), with the disorders. Government-Owned Inventions; desired pharmacological and Contact Information: Requests for Availability for Licensing and/or Co- pharmacokinetic profile. For example, copies of the patent application or Development metabolic instability or predicted inquiries about licensing, research toxicity has precluded successful collaborations, and co-development AGENCY: National Institutes of Health, opportunities should be sent to John D. Department of Health and Human translation of previously reported D3R- selective antagonists to clinical use for Hewes, Ph.D., email: john.hewes@ Services. nih.gov. ACTION: Notice. cocaine abuse. The library of compounds is designed Dated: November 10, 2016. SUMMARY: The invention listed below is to have high affinity and specificity for John D. Hewes, owned by an agency of the U.S. the dopamine D3 receptor. Preliminary Technology Transfer Specialist, Technology Government and is available for studies at National Institute of Drug Transfer Center, National Cancer Institute. licensing and/or co-development in the Abuse (NIDA) indicate that selected [FR Doc. 2016–27770 Filed 11–17–16; 8:45 am] U.S. to achieve expeditious lead compounds have promising in vivo BILLING CODE 4140–01–P commercialization of results of activity in rodents, including reduced federally-funded research and acquisition to self-administration of development. Foreign patent oxycodone, inhibition of reinstatement DEPARTMENT OF HEALTH AND applications are filed on selected to oxycodone seeking, and ameliorating HUMAN SERVICES inventions to extend market coverage naloxone-precipitated withdrawal from for companies and may also be available oxycodone dependence. National Institutes of Health for licensing and/or co-development. This invention is owned by an agency of the U.S. Government and is available Submission for OMB Review; 30-Day ADDRESSES: Invention Development and for licensing and/or co-development in Comment Request: A National Survey Marketing Unit, Technology Transfer the U.S., in accordance with 35 U.S.C. of Nurse Coaches (NIH Clinical Center) Center, National Cancer Institute, 9609 Medical Center Drive, Mail Stop 9702, 209 and 37 CFR part 404, to achieve AGENCY: National Institutes of Health. Rockville, MD 20850–9702. expeditious commercialization of ACTION: Notice. FOR FURTHER INFORMATION CONTACT: results of federally-funded research and Information on licensing and co- development. Foreign patent SUMMARY: In compliance with the development research collaborations, applications are filed on selected Paperwork Reduction Act of 1995, the and copies of the U.S. patent inventions to extend market coverage National Institutes of Health (NIH) has applications listed below may be for companies and may also be available submitted to the Office of Management obtained by contacting: Attn. Invention for licensing and/or co-development. and Budget (OMB) a request for review Development and Marketing Unit, Potential Commercial Applications: and approval of the information Technology Transfer Center, National • Treatment of Opioid Use Disorders collection listed below. This proposed Cancer Institute, 9609 Medical Center • Treatment of Schizophrenia information collection was previously Drive, Mail Stop 9702, Rockville, MD • Treatment of Bipolar Disorder published in the Federal Register on 20850–9702, Tel. 240–276–5515 or • Treatment of cannabis August 22, 2016, pages 56668–9 (81 FR email ncitechtransfer@mail.nih.gov. A (Tetrahydrocannabinol, THC) 56668) and allowed 60-days for public signed Confidential Disclosure dependence comment. No public comments were Agreement may be required to receive Value Proposition: Despite extensive received. The purpose of this notice is copies of the patent applications. efforts to develop D3 receptor-selective to allow an additional 30 days for public SUPPLEMENTARY INFORMATION: compounds, it has proven difficult to comment. Technology description follows. identify a ligand with the desired DATES: Comments regarding this Title of invention: Methods of Making pharmacological and pharmacokinetic information collection are best assured mstockstill on DSK3G9T082PROD with NOTICES and Using Dopamine D3 Receptor profile for translation to the clinic. The of having their full effect if received by Selective Antagonists/Partial Agonists D3 receptor ligands described herein December 19, 2016. Summary of Technology: A library of may be useful to treat a variety of ADDRESSES: Written comments and/or novel compounds that selectively bind diseases, including opioid use disorders suggestions regarding the item(s) the dopamine D3 receptor have been and schizophrenia. contained in this notice, especially designed and characterized extensively. Development Stage: Pre-clinical (in regarding the estimated public burden In vivo rodent studies indicate selected vivo validation). and associated response time, should be VerDate Sep<11>2014 20:21 Nov 17, 2016 Jkt 241001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\18NON1.SGM 18NON1

81788 Federal Register / Vol. 81, No. 223 / Friday, November 18, 2016 / Notices directed to the: Office of Management that has been extended, revised, or outcomes followed, as well as the and Budget, Office of Regulatory Affairs, implemented on or after October 1, personal benefits experienced by nurse OIRA_submission@omb.eop.gov or by 1995, unless it displays a currently valid coaches as a result of becoming a nurse fax to 202–395–6974, Attention: Desk OMB control number. coach. It provides information regarding Officer for NIH. In compliance with Section two areas of interest to the Department FOR FURTHER INFORMATION CONTACT: To 3507(a)(1)(D) of the Paperwork of Nursing Research and Translational request more information on the Reduction Act of 1995, the National Science: The collection of patient- proposed project or to obtain a copy of Institutes of Health (NIH) has submitted reported outcomes in novel clinical the data collection plans and to the Office of Management and Budget practice areas and the physical and instruments, contact: Dr. Alyson Ross, (OMB) a request for review and psychosocial benefits of an intervention Nurse Researcher, Department of approval of the information collection in nurses, a professional caregiver Nursing Research and Translational listed below. population. This study will provide Science, NIH Clinical Center, Building Proposed Collection: A National preliminary data and guidance in: (1) 10, Room 2B07, MSC–1151, Bethesda, Survey of Nurse Coaches, 0925–NEW, Developing recommendations for Maryland, 20892 or call non-toll-free National Institutes of Health Clinical collecting outcomes to longitudinally number (301) 451–8338 or Email your Center (NIHCC), National Institutes of assess the effectiveness nurse coaching, request, including your address to: Health (NIH). Alyson.ross@nih.gov. Formal requests and (2) developing an intervention to Need and Use of Information for additional plans and instruments improve patient care and patient Collection: The purpose of this survey is must be requested in writing. to describe the role of Certified Nurse satisfaction targeting the nursing staff at SUPPLEMENTARY INFORMATION: The NIH Coaches in order to gain insight into the NIH Clinical Center. Clinical Center, National Institutes of their clinical practice including: The OMB approval is requested for 1 year. Health, may not conduct or sponsor, settings in which they work, the types There are no costs to respondents other and the respondent is not required to of clients/health conditions they see, the than their time. The total estimated respond to, an information collection types of client records maintained and annualized burden hours are 104. ESTIMATED ANNUALIZED BURDEN HOURS Number of Average time Number of Total annual Type of respondent responses per per response respondents burden hours respondent (in hours) Certified Nurse Coaches ................................................................................. 250 1 25/60 104 Total .......................................................................................................... 250 250 ........................ 104 Dated: November 9, 2016. stern light, and towing light provisions unable to comply with the light, shape, Laura M. Lee, of the 72 COLREGS without interfering and sound signal provisions of the 72 Project Clearance Liaison, NIH Clinical with its ability to make up and assist COLREGS. Under statutory law 1 and Center, National Institutes of Health. other vessels. This notice promotes the Coast Guard regulation,2 a vessel may [FR Doc. 2016–27839 Filed 11–17–16; 8:45 am] Coast Guard’s maritime safety and instead meet alternative requirements BILLING CODE 4140–01–P stewardship missions. and the vessel’s owner, builder, ADDRESSES: Documents mentioned in operator, or agent may apply for a the preamble are part of docket USCG– COAC. For vessels of special DEPARTMENT OF HOMELAND 2016–0965. To view documents construction, the cognizant Coast Guard SECURITY mentioned in this preamble as being District Office determines whether the available in the docket, go to the Federal vessel for which the COAC is sought Coast Guard eRulemaking Portal at http:// complies as closely as possible with the www.regulations.gov, type the docket 72 COLREGS, and decides whether to [Docket No. USCG–2016–0965] issue the COAC. Once issued, a COAC number in the ‘‘SEARCH’’ box and click ‘‘SEARCH.’’ Click on Open Docket remains valid until information Certificate of Alternative Compliance supplied in the COAC application or the for the TUG MAXWELL PAUL MORAN Folder on the line associate with this notice. COAC terms become inapplicable to the AGENCY: Coast Guard, DHS. vessel. Under the governing statute 3 FOR FURTHER INFORMATION CONTACT: For and regulation,4 the Coast Guard must ACTION: Notice. information or questions about this publish notice of this action. SUMMARY: The Coast Guard announces notice call or email Mr. Kevin Miller, First District Towing Vessel/Barge The Prevention Department’s that the First District Prevention Inspection and Investigation Division, Department’s Inspections and Safety Specialist, U.S. Coast Guard; telephone (617) 223–8272, email U.S. Coast Guard First District hereby Investigations Division has issued a finds and certifies that the TUG Certificate of Alternate Compliance <Kevin.L.Miller2@uscg.mil>. mstockstill on DSK3G9T082PROD with NOTICES MAXWELL PAUL MORAN is a vessel of (COAC) from the International SUPPLEMENTARY INFORMATION: special construction or purpose, and Regulations for Preventing Collisions at The United States is signatory to the that, with respect to the position of the Sea, 1972 (72 COLREGS) for the TUG International Maritime Organization’s MAXWELL PAUL MORAN as required International Regulations for Preventing 1 33 U.S.C. 1605(c). by statue. Due to its operations as a Collisions at Sea, 1972 (72 COLREGS), 2 33 CFR 81.3. harbor assistance and escort vessel it as amended. The special construction or 3 33 U.S.C. 1605(c). cannot fully comply with the sidelight, purpose of some vessels makes them 4 33 CFR 81.18. VerDate Sep<11>2014 20:21 Nov 17, 2016 Jkt 241001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\18NON1.SGM 18NON1


Document Created: 2018-02-14 08:31:42
Document Modified: 2018-02-14 08:31:42
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesComments regarding this information collection are best assured of having their full effect if received by December 19, 2016.
ContactTo request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. Alyson Ross, Nurse Researcher, Department of Nursing Research and Translational Science, NIH Clinical Center, Building 10, Room 2B07, MSC-1151, Bethesda, Maryland, 20892 or call non-toll-free number (301) 451-8338 or Email your request, including
FR Citation81 FR 81787 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR